Immunohistochemical analysis usually demonstrates a “vimentin-only” phenotype, excluding some other neoplasms such as sarcomatoid variants of squamous cell carcinoma, spindle cell carcinoma, vascular tumors, or synovial sarcoma—showing negative to their markers. This evidence concerns the gene VIM and synovial sarcoma.